Monte Rosa Therapeutics, Inc. GLUE Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s operating lease liabilities?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease liabilities of $34.58M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating lease liabilities decreased by 9.0% year-over-year, from $38M to $34.58M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.